Capricor Therapeutics, Inc. logo

Capricor Therapeutics, Inc.

NASDAQ:CAPR

Overview | Financials
Company Name Capricor Therapeutics, Inc.
Symbol CAPR
Currency USD
Price 14.13
Market Cap 642,489,687
Dividend Yield 0%
52-week-range 3.52 - 23.4
Industry Biotechnology
Sector Healthcare
CEO Dr. Linda Marbán Ph.D.
Website https://www.capricor.com

An error occurred while fetching data.

About Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with

Related Stocks

Tabula Rasa HealthCare, Inc. logo

Tabula Rasa HealthCare, Inc.

TRHC

10.5 USD

Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc.

LUCD

0.775 USD

Cytosorbents Corporation logo

Cytosorbents Corporation

CTSO

0.838 USD

Xilio Therapeutics, Inc. logo

Xilio Therapeutics, Inc.

XLO

1.11 USD

Adverum Biotechnologies, Inc. logo

Adverum Biotechnologies, Inc.

ADVM

4.74 USD

Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc.

ALZN

1.15 USD

HOOKIPA Pharma Inc. logo

HOOKIPA Pharma Inc.

HOOK

2.03 USD

Financials

Numbers are in millions USD

Numbers are in millions USD